Completion lymph node dissection for merkel cell carcinoma - 27/09/20
, Krish Suresh b, Shaum Sridharan cAbstract |
Background |
Sentinel lymph node biopsy (SLNB) is widely used for Merkel cell carcinoma (MCC), however in SLNB positive MCC the role of completion lymph node dissection (CLND) with or without adjuvant radiation therapy is unclear.
Objective |
Our goal was to determine the impact of CLND and adjuvant radiation therapy on survival in SLNB positive MCC.
Materials and methods |
We examined 447 patients with MCC with a positive SLNB in the National Cancer Data Base from 2012 to 2015. We compared patients who underwent CLND versus observation with or without adjuvant radiation.
Results |
Compared with CLND and adjuvant radiation (reference) treatment with observation (HR 3.54, CI 1.36–9.18) or CLND alone (HR 2.54, CI 1.03–6.27) were associated with worse overall survival after adjusting for clinicopathologic differences. In contrast treatment with adjuvant radiation alone without CLND was not associated with worse overall survival (HR 1.70, CI 0.74–3.92) compared with CLND and adjuvant radiation (reference).
Conclusions |
In SLNB positive MCC, CLND alone is associated with worse survival compared with treatment with adjuvant radiation or both CLND and adjuvant radiation.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Treatment after a positive SLNB for Merkel cell carcinoma remains a dilemma. |
• | We analyzed 447 patients with a positive SLNB in a national cancer database. |
• | We found that radiation with or without CLND improved survival. |
Keywords : Merkel cell carcinoma, Sentinel lymph node biopsy, Completion lymph node dissection, National cancer database
Plan
Vol 220 - N° 4
P. 982-986 - octobre 2020 Retour au numéro
Article précédent
- Duodenal stump leakage. Lessons to learn from a large-scale 15-year cohort study
- Yam Po Chu Patricia, Wong Ka Fai Kevin, Lam Fong Yee, Fung Kiu Jing, Szeto Kylie, Leung Siu Kee
- Disparities in neoadjuvant radiation dosing for treatment of rectal cancer
- Asya Ofshteyn, Katherine Bingmer, Jennifer Dorth, David Dietz, Emily Steinhagen, Sharon L. Stein
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?